We noticed you are on our US page. Want to switch regions? Choose from the options:

Prostate specific membrane antigen (PSMA PET)

Providing patients with access to world-class physicians and facilities ensuring high-quality, evidence-based cancer care close to home.

Leading experts

GenesisCare is one of the first medical centers in the US offering FDA approved PSMA PET to deliver the best possible life outcomes. PSMA PET is most effective and precise for localizing metastatic prostate cancer. With PSMA PET scans, we use targeted imaging to detect areas of suspected metastasis for initial therapy and suspected recurrence based on an elevated serum prostate-specific antigen (PSA) level.

PSMA PET with GenesisCare

PSMA (prostate-specific membrane antigen) PET imaging will significantly improve how prostate cancer is detected and treated.

A PSMA PET/CT scan is a type of PET/CT scan using two types of scans – positron emission tomography (PET) and computed tomography (CT) – and a special radiotracer to detect prostate cancer within the prostate and that has spread throughout the body. It is used if you have been diagnosed with prostate cancer to assess whether it has spread.

The radiotracer is a special substance that is injected into your body before the scan and is attracted to a substance in the body called prostate specific membrane antigen (PSMA). PSMA is a type of protein found in high concentrations on the surface of prostate cancer cells, including those that have spread to other parts of your body. The radiotracer can be detected by the PET/CT scan, showing where the cancer has spread and also indicating how it may respond to certain treatments. These results provide extremely detailed information to help your doctor plan your care.

 

At GenesisCare, we are finding new ways to care for your patients. We are one of the first medical centers in the US offering FDA approved PSMA PET to deliver the best possible life outcomes. With the release of the PSMA PET scans, we can enhance the way to test for metastatic prostate cancer by using targeted imaging to detect areas of suspected metastasis for initial therapy and suspected recurrence based on an elevated serum prostate-specific antigen (PSA) level.*

Find a PSMA PET GenesisCare center,** close to you:

 

*Based on FDA approved clinical indications

** PSMA supply subject to availability per location

***PSMA PET is available at select GenesisCare sites that provide PET imaging.

Get in touch

Contact us today to find out more about how GenesisCare can help you

 

Contact us

Here to help

/content/dam/asset-migration/lifestyle/iStock-992097020.jpg

Financial and insurance information

We know you may be worried about your insurance and how much of your treatment it will cover. That’s why each of our locations has a dedicated Office Financial Counselor on hand to help you with your paperwork and answer your questions. We accept most insurance plans as well as Medicare Part B, which covers physician services.

Find your nearest center